View more in
Stocks

Here’s Why Boston Scientific Is Undervalued At $43 Levels

Forbes
 2021-06-18

Cover picture for the articleWe believe that the stock price of Boston Scientific (NYSE: BSX) is undervalued at current levels of $43. BSX stock is up 65% from the levels of around $26 it was at on March 23, 2020, underperforming the broader markets with the S&P 500 rising 89% over the same period. The demand for medical devices remained sluggish for the better part of 2020, due to the postponement of elective surgeries, weighing on Boston Scientific’s stock performance.

www.forbes.com

Comments / 0

Comments / 0